High prevalence of exocrine pancreatic insufficiency in diabetes mellitus: A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients

Pancreatology

Volumn 3, Issue 5, 2003, Pages 395-402

  Hardt, Philip D ^a   Hauenschild, Annette ^a   Nalop, Jens ^a   Marzeion, Axel M ^a   Jaeger, Clemens ^a   Teichmann, Joachim ^a   Bretzel, Reinhard G ^a   Hollenhorst, Manfred ^b   Kloer, Hans U ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Exocrine pancreatic function; Pancreatitis, fecal elastase 1 concentration; Type 1 diabetes mellitus; Type 2 diabetes mellitus

Indexed keywords

ALCOHOL; ELASTASE; INSULIN; ISOENZYME;

ADULT; AGED; ALCOHOL ABUSE; ANAMNESIS; ARTICLE; BODY MASS; CARCINOMA; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SURGERY; HUMAN; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PANCREAS FUNCTION; PANCREAS INSUFFICIENCY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SCREENING; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

EID: 0242657573     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000073655     Document Type: Article

References (44)

1. Chey WY, Shay H, Shuman CR: External pancreatic secretion in diabetes mellitus. Ann Intern Med 1963;59:812-821.
2. Vacca JB, Henke WJ, Knight WA: The exo-crine pancreas in diabetes mellitus. Ann Intern Med 1964;61:242-247.
3. Frier BM, Saunders JHB, Wormsley KG, Bou-chier IAD: Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut 1976;17:685-691.
4. Lankisch PG, Manthey G, Otto J, Talaulicar M, Willms B, Creutzfeldt W: Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion 1982;25:210-216.
5. Gilbeau J, Poncelet V, Libon E, Derue G, Hel-ler FR: The density, contour and thickness of the pancreas in diabetics. Am J Roentgenol 1992;159:527-531.
6. Lazarus SS, Volk BW: Pancreas in maturity-onset diabetes. Arch Pathol (Chicago) 1961;71:44-48.
7. Gepts W: Pathology of the pancreas in juvenile diabetes. Diabetes 1965;14:619-633.
8. Loehr M, Kloeppel G: Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabeto-logia 1987;30:757-762.
9. Kobayashi T, Nakanishi K, Sugimoto T, Mu-rase T, Kosaka K: Histopathological changes of the pancreas in islet cell antibodies (ICA)-positive subjects before and after the clinical onset of insulin-dependent diabetes mellitus. Diabetes 1988;37:24A.
10. Nakanishi K, Kobayashi T, Miyashita H, Oku-bo M, Sugimoto T, Murase T et al: Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am J Gastroenterol 1994;89:762-766.
11. Hardt PD, Killinger A, Nalop J, Schnell-Kretschmer H, Zekorn T, Kloer HU: Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin- dependent diabetes mellitus. Pancreatology 2002;2:30-33.
12. Nakamura Z, Imamura K, Takebe K, Terada A, Arai Y, Tandoh Y et al: Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis. Int J Pancreatol 1996;20:169-175.
13. Warren KW, Fallis LS, Barron J: Acute pancreatitis and diabetes. Ann Surg 1950;132:1003-1010.
14. Larsen S: Diabetes secondary to chronic pancreatitis. Dan Med Bull 1993;40:153-162.
15. Alberti KGMM: Diabetes secondary to pancreatopathy: An example of brittle diabetes; in Tiengo A, Alberti KGMM, DelPrato S, Vranic M (eds): Diabetes Secondary to Pancreatopa-thy. Amsterdam, Excerpta Medica, 1988, pp 7-20.
16. Williams JA, Goldfine ID: The insulin-pancreatic acinar axis. Diabetes 1985;34:980-986.
17. Henderson JR: Why are the islets of Langer-hans? Lancet 1969;ii:469-470.
18. El Ne Wihi H, Dooley CP, Saad C: Impaired exocrine pancreatic function in diabetics with diarrhoea and peripheral neuropathy. Dig Dis Sci 1988;33:705-710.
19. Dyck WP, Rudick J, Hoexter B, Janowitz HD: Influence of glucagon on pancreatic exocrine secretion. Gastroenterology 1969;56:531-537.
20. Unger RH, Aguilar-Parada E, Mueller WA, Ei-sentraut AM: Studies of pancreaticαcell function in normal and diabetic subjects. J Clin Invest 1970;49:837-848.
21. Korc M: Islet growth factors: Curing diabetes and preventing chronic pancreatitis? J Clin Invest 1993;92:113-114
22. Lazarus SS, Volk BW: The effect of protracted glucagon administration on blood glucose and on pancreatic morphology. Endocrinology 1958;63:359-371.
23. Kobayashi T, Nakanishi K, Kajio H, Morinaga S, Sugimoto T, Murase T et al: Pancreatic cyto-keratin: An antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990;33:363-370.
24. Mally IM, Cirulli V, Hayek A, Otonkosky T: ICA-69 is expressed equally in the human endocrine and exocrine pancreas. Diabetologia 1996;39:474-480.
25. Sanvito F, Nicols A, Herrera PJ, Huarte J, Wohlwend A, Vassali JD et al: TGF-(β)1(overex-)pression in murine pancreas induces chronic pancreatitis and, together with TNF-α, triggers insulin-dependent diabetes. Biochem Biophys Res Commun 1995;217:1279-1286.
26. Hardt PD, Krauss A, Bretz L, Porsch-Oezcue-ruemez M, Schnell-Kretschmer H, Maeser E et al: Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol 2000;37:105-110.
27. Rathmann W, Haastert B, Icks A, Giani G, Hennings S, Mitchell J et al: Low fecal elastase 1 concentrations in type 2 diabetes. Scand J Gastroenterol 2001;36:1056-1061.
28. Icks A, Haastert B, Giani G, Rathmann W: Low fecal elastase 1 in type 1 diabetes mellitus. Z Gastroenterol 2001;39:823-830.
29. Hardt PD, Hauenschild A, Jaeger C, Teich-mann J, Bretzel RG, Kloer HU and the S2453112/S2453113 Study Group: High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: A prospective multicenter study. Dig Dis Sci 2003; in press.
30. Loeser C, Moellgaard A, Foelsch UR: Faecal elastase 1: A novel, highly sensitive and specific tubeless pancreatic function test. Gut 1996;39:580-586.
31. Stein J, Jung M, Sziegoleit A, Zeuzem S, Caspa-ry WF, Lembcke B: Immunoreactive elastase 1: Clinical evaluation of a new noninvasive test of pancreatic function. Clin Chem 1996;42:222-226.
32. Hardt PD, Marzeion AM, Schnell-Kretschmer H, Wuesten O, Nalop J, Zekorn T et al: Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis. Pancreas 2002;25:E6-E9.
33. Lankisch PG, Schmidt I, Koenig H et al: Faecal elastase 1: Not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998;42:551-554.
34. Lueth S, Teyssen S, Forssmann K, Koelbel C, Krummenauer F, Singer MV: Fecal elastase 1 determination: 'Gold standard' of indirect pancreatic function tests? Scand J Gastroenterol 2001;36:1092-1099.
35. Fischer B, Hoh S, Wehler M, Hahn EG, Schneider HT: Faecal elastase 1: Lyophilization of stool samples prevents false low results in diarrhoea. Scand J Gastroenterol 2001;36:771-774.
36. Carroccio A, Verghi F, Santini B, Lucidi V, Iacono G, Cavataio F et al: Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorp-tion: A collaborative study of the Italian Society of Pediatric Gastroenterology and Hepa-tology. Dig Dis Sci 2001;46:1335-1342.
37. Walkowiak J, Herzig KH: Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease. Eur J Clin Invest 2001;31:425-430.
38. Adler G, Kern HF: Regulation of exocrine pancreatic secretory process by insulin in vivo. Horm Metab Res 1975;7:290-296.
39. Aparisi QL, Sabater OL, Calvete CJ, Camps VB, Sastre BJ, Bautista RD et al: Early carbohydrate metabolism dysfunction in chronic pancreatitis. Relation with the exocrine pancreatic function. Med Clin (Barc) 2001;117:561-566.
40. Moran CE, Sosa EG, Martinez SM, Geldern P, Messina D, Russo A et al: Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol 1997;92:867-871.
41. Teichmann J, Lange U, Hardt P, Schnell-Kretschmer H, Stracke H, Bretzel RG et al: Decreased pancreatic elastase 1 content: An independent risk factor of the osteoporosis in elderly women. Bone 2001;28(suppl):194.
42. Glasbrenner B, Malfertheiner P, Kerner W, Scherbaum WA, Ditschuneit H: Effect of pancreatin on diabetes mellitus in chronic pancreatitis. Z Gastroenterol 1990;28:275-279.
43. O'Keefe SJ, Cariem AK, Levy M: The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gas-troenterol 2001;32:319-323.
44. Mohan V, Poongothai S, Pitchumoni CS: Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. Int J Pancreatol 1998;24:19-22.